iRhythm Holdings IRTC
NASDAQ IRTC
$127.95 +3.20 (+2.57%)
As of: Aug 20, 2026 · 3:59 PM EDT

iRhythm Holdings (IRTC) Liabilities and Shareholders Equity (2015 - 2026)

iRhythm Holdings (IRTC) posted quarterly Liabilities and Shareholders Equity of $1.0 billion for Q1 2026, up 8.67% year-over-year from $926.1 million in Q1 2025, and down 1.34% quarter-over-quarter from $1.0 billion in Q4 2025.

iRhythm Holdings (IRTC) Liabilities and Shareholders Equity (2015 - 2026) Analysis & Trends

iRhythm Holdings (IRTC) has reported Liabilities and Shareholders Equity for 12 consecutive years, with $1.0 billion the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity rose 8.67% year-over-year to $1.0 billion; the TTM figure through Mar 2026 stood at $4.0 billion (up 8.12% YoY), while the FY2025 annual figure was $1.0 billion, up 9.51% from the prior year.
  • Liabilities and Shareholders Equity fell to $1.0 billion in Q1 2026 per IRTC's latest filing, from $1.0 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $1.0 billion in Q4 2025 and bottomed at $421.7 million in Q1 2023.
  • Historically, Liabilities and Shareholders Equity has averaged $709.3 million across 5 years, with a median of $909.7 million in 2024.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity fell 10.4% — and 2024, when it jumped 115.73%.
  • iRhythm Holdings' Liabilities and Shareholders Equity stood at $448.2 million in 2022, then decreased by 3.36% to $433.1 million in 2023, then soared by 115.04% to $931.4 million in 2024, then increased by 9.51% to $1.0 billion in 2025, then slipped by 1.34% to $1.0 billion in 2026.
  • Business Quant data shows IRTC's Liabilities and Shareholders Equity at $1.0 billion in Q1 2026, $1.0 billion in Q4 2025, and $995.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn 109.22 Bn
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 47.93 Bn
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 93.03 Bn
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 45.22 Bn
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 13.87 Bn
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 6.46 Bn
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 37.25 Bn
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 31.04 Bn
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 10.74 Bn
10 iRhythm Holdings 4.23 Bn 3.64 Bn 163.21 Mn 1.09 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.09 Bn
Mar 31, 2026 1.01 Bn
Dec 31, 2025 1.02 Bn
Sep 30, 2025 995.21 Mn
Jun 30, 2025 964.03 Mn
Mar 31, 2025 926.10 Mn
Dec 31, 2024 931.45 Mn
Sep 30, 2024 909.69 Mn
Jun 30, 2024 919.19 Mn
Mar 31, 2024 909.76 Mn
Dec 31, 2023 433.14 Mn
Sep 30, 2023 439.77 Mn
Jun 30, 2023 429.49 Mn
Mar 31, 2023 421.70 Mn
Dec 31, 2022 448.22 Mn
Sep 30, 2022 440.39 Mn
Jun 30, 2022 435.69 Mn
Mar 31, 2022 428.72 Mn
Dec 31, 2021 462.97 Mn
Sep 30, 2021 480.25 Mn